Association between promoter polymorphisms in anterior pharynx-defective-1a and sporadic Alzheimer's disease in the North Chinese Han population

Neuroscience Letters

Volumn 455, Issue 2, 2009, Pages 101-104

  Wang, Yan ^a   Jia, Jianping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; APH 1a; Polymorphism; Promoter

Indexed keywords

ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 63649103805     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.02.015     Document Type: Article

References (22)

1. Arawaka S., Hasegawa H., Tandon A., Janus C., Chen F., Yu G., Kikuchi K., Koyama S., Kato T., Fraser P.E., and St George-Hyslop P. The levels of mature glycosylated nicastrin are regulated and correlate with gamma-secretase processing of amyloid beta-precursor protein. J. Neurochem. 83 (2002) 1065-1071
2. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol. 82 (1991) 239-259
3. Campbell W.A., Iskandar M.K., Reed M.L., and Xia W. Endoproteolysis of presenilin in vitro: inhibition by gamma-secretase inhibitors. Biochemistry 41 (2002) 3372-3379
4. Coles R., Caswell R., and Rubinsztein D.C. Functional analysis of the Huntington's disease (HD) gene promoter. Hum. Mol. Genet. 7 (1998) 791-800
5. De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron 38 (2003) 9-12
6. Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J., Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J., Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S., and Curtis D. Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3 (2002) 85-97
7. Goutte C., Tsunozaki M., Hale V.A., and Priess J.R. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 775-779
8. Hu Y., and Fortini M.E. Different cofactor activities in gamma-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex. J. Cell. Biol. 161 (2003) 685-690
9. Iwatsubo T. The gamma-secretase complex: machinery for intramembrane proteolysis. Curr. Opin. Neurobiol. 14 (2004) 379-383
10. Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W.M., Wolfe S., and Selkoe D.J. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6382-6387
11. Lambert J.C., Mann D.M., Harris J.M., Chartier-Harlin M.C., Cumming A., Coates J., Lemmon H., StClair D., Iwatsubo T., and Lendon C. The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain. J. Med. Genet. 38 (2001) 353-355
12. Luo W.J., Wang H., Li H., Kim B.S., Shah S., Lee H.J., Thinakaran G., Kim T.W., Yu G., and Xu H. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J. Biol. Chem. 278 (2003) 7850-7854
13. Lv H., Jia L., and Jia J. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease. Neurobiol. Aging 29 (2008) 194-202
14. Ma G., Li T., Price D.L., and Wong P.C. APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development. J. Neurosci. 25 (2005) 192-198
15. Niimura M., Isoo N., Takasugi N., Tsuruoka M., Ui-Tei K., Saigo K., Morohashi Y., Tomita T., and Iwatsubo T. Aph-1 contributes to the stabilization and trafficking of the gamma-secretase complex through mechanisms involving intermolecular and intramolecular interactions. J. Biol. Chem. 280 (2005) 12967-12975
16. Poli M., Gatta L.B., Archetti S., Padovani A., Albertini A., and Finazzi D. Association analysis between anterior-pharynx defective-1 genes polymorphisms and Alzheimer's disease. Neurosci. Lett. 350 (2003) 77-80
17. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
18. Serneels L., Dejaegere T., Craessaerts K., Horre K., Jorissen E., Tousseyn T., Hebert S., Coolen M., Martens G., Zwijsen A., Annaert W., Hartmann D., and De Strooper B. Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1719-1724
19. Terry R.D. Neuropathological changes in Alzheimer disease. Prog. Brain Res. 101 (1994) 383-390
20. Terwilliger J.D., and Ott J. Linkage disequilibrium between alleles at marker loci. Handbook of Human Genetic Linkage (1994), The John Hopkins University Press, Baltimore, MD pp. 188-198
21. Tsai M.S., Tangalos E.G., Petersen R.C., Smith G.E., Schaid D.J., Kokmen E., Ivnik R.J., and Thibodeau S.N. Apolipoprotein E: risk factor for Alzheimer disease. Am. J. Hum. Genet. 54 (1994) 643-649
22. Wang C.K., Chen C.M., Chang C.Y., Chang K.H., Chen I.C., Li M.L., Lee-Chen G.J., and Wu Y.R. Alpha-synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease. J. Neural. Transm. 113 (2006) 1425-1433